Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Receivables (2022 - 2025)

Historic Receivables for Jin Medical International (ZJYL) over the last 4 years, with Q3 2025 value amounting to $7.0 million.

  • Jin Medical International's Receivables fell 1782.7% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year decrease of 1782.7%. This contributed to the annual value of $7.0 million for FY2025, which is 1782.7% down from last year.
  • Per Jin Medical International's latest filing, its Receivables stood at $7.0 million for Q3 2025, which was down 1782.7% from $4.4 million recorded in Q1 2025.
  • Jin Medical International's 5-year Receivables high stood at $8.7 million for Q1 2023, and its period low was $2.7 million during Q3 2023.
  • For the 4-year period, Jin Medical International's Receivables averaged around $5.6 million, with its median value being $4.4 million (2025).
  • Data for Jin Medical International's Receivables shows a peak YoY increase of 21515.25% (in 2024) and a maximum YoY decrease of 5515.04% (in 2024) over the last 5 years.
  • Jin Medical International's Receivables (Quarter) stood at $4.0 million in 2022, then plummeted by 32.26% to $2.7 million in 2023, then surged by 215.15% to $8.5 million in 2024, then dropped by 17.83% to $7.0 million in 2025.
  • Its Receivables was $7.0 million in Q3 2025, compared to $4.4 million in Q1 2025 and $8.5 million in Q3 2024.